BSF Enterprise plc (BSFA) ORD GBP0.01

Sell:1.25pBuy:1.50pNo change

Prices delayed by at least 15 minutes
Sell:1.25p
Buy:1.50p
Change:No change
Prices delayed by at least 15 minutes
Sell:1.25p
Buy:1.50p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.

Key people

Che Connon
Chief Executive Officer, Executive Director
Geoffrey Robert Baker
Executive Director, Company Secretary
Min Yang
Non-Executive Chairman of the Board
Kian Jing Ow
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    BSFA
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BHNBDQ51
  • Market cap
    £1.70m
  • Employees
    4
  • Shares in issue
    123.65m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.